DECONGESTION STRATEGIES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN ACUTE HEART FAILURE
Robert J. Mentz(Duke University), G. Michael Felker(Clinical Research Institute), Kevin Anstrom(PragmatIC (United Kingdom)), Bradley A. Bart(Hennepin County Medical Center), Margaret M. Redfield(Mayo Clinic in Arizona), Susanna Stevens(Clinical Research Institute), Eugene Braunwald(Brigham and Women's Hospital), Lynne W. Stevenson(Vanderbilt University Medical Center), Steven E. McNulty, Anu Lala(Clinical Research Institute), Omar F. AbouEzzeddine(Mayo Clinic), Justin Vader, Prateeti Khazanie, Adam D. DeVore(Duke University), Steven R. Goldsmith(Hennepin Healthcare Research Institute), Monica Shah(Clinical Research Institute), Christopher M. O’Connor(Inova Health System), Adrian F. Hernandez(Duke University)
Cited by 4
Related Papers
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k